glp 1 commercial Serena Williams is in a new ad campaign for weight loss medication (GLP-1 from Ro), but this is a complex story with two very different sides. Is this a brave move to normalize the medication or a The Unstoppable Rise of The

"Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin"

Pilichiewicz AN, Chaikomin R, Brennan IM et al (2007) Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men

Side effects can have varying impacts on individuals as everyone is different

Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells

GLP-1 receptor agonists, marketed under names like Ozempic and Wegovy, are being taken by millions of people worldwide, not only for Type 2 diabetes but also as quick solutions for weight loss

It says it will remove products from the market if they claim to treat or change how the body works if they are not licensed under the Human Medicines Regulations Act 2012, and that it strongly advises against purchasing and using unauthorised medicinal products - "particularly those promoted on social media"